Marrero, Jorge A MD¹; Ahn, Joseph MD, FACG²; Reddy, Rajender K MD, FACG³ on behalf of the Practice Parameters Committee of the American College of Gastroenterology
¹University of Texas at Southwestern, Dallas, Texas, USA
²Oregon Health and Science University, Portland, Oregon, USA
³University of Pennsylvania, Philadelphia, Pennsylvania, USA

American Journal of Gastroenterology: September 2014 – Volume 109 – Issue 9 – p 1328–1347. doi: 10.1038/ajg.2014.213.
Приводится в сокращении. Отобран материал для применения в практической деятельности детских хирургов. Полный текст по ссылке: https://journals.lww.com/ajg/fulltext/2014/09000/acg_clinical_guideline__the_diagnosis_and.7.aspx

ЛІТЕРАТУРА

1. Bruix J, Sherman M, American Association for the Study of Liver. Management of hepatocellular carcinoma: an update. Hepatology 2011;53:1020–1022.

2. Khan SA, Davidson BR, Goldin RD et al. Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update. Gut 2012;61:1657–1669.

3. European Association For The Study Of The Liver; European Organisation For Research And Treatment Of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2012;56:908–943.

4. Guyatt GH, Oxman AD, Vist GE et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336:924–926.

5. Smith-Bindman R, Miglioretti DL, Johnson E et al. Use of diagnostic imaging studies and associated radiation exposure for patients enrolled in large integrated health care systems, 1996–2010. JAMA 2012;307:2400–2409.

6. Ros PR, Mortele KJ. Hepatic imaging. An overview. Clin Liver Dis 2002;6:1–16.

7. Pomfret EA, Washburn K, Wald C et al. Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States. Liver Transpl 2010;16:262–278.

8. Di Martino M, De Filippis G, De Santis A et al. Hepatocellular carcinoma in cirrhotic patients: prospective comparison of US CT and MR imaging. Eur Radiol 2013;23:887–896.

9. Quinn SF, Nelson HA, Demlow TA. Thyroid biopsies: fine-needle aspiration biopsy versus spring-activated core biopsy needle in 102 patients. J Vasc Interv Radiol 1994;5:619–623.

10. International Consensus Group for Hepatocellular NeoplasiaThe International Consensus Group for Hepatocellular Neoplasia. Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia. Hepatology 2009;49:658–664.

<…>

52. Shaked O, Siegelman ES, Olthoff K et al. Biologic and clinical features of benign solid and cystic lesions of the liver. Clin Gastroenterol Hepatol 2011;9:547–562 e1–4.

53. Craig JR, Peters RL, Edmondson HA et al. Tumors of the liver and intrahepatic bile ducts. Atlas of Tumor Pathology, Washington, DC: Armed Forces Institute of Pathology: Supt. of Docs., U.S. G.P. O. For sale by the Armed Forces Institute of Pathology. 280 p 1989.

<…>

90. Karhunen PJ. Benign hepatic tumours and tumour like conditions in men. J Clin Pathol 1986;39:183–188.

91. Gibney RG, Hendin AP, Cooperberg PL. Sonographically detected hepatic hemangiomas: absence of change over time. AJR Am J Roentgenol 1987;149:953–957.

92. Rungsinaporn K, Phaisakamas T. Frequency of abnormalities detected by upper abdominal ultrasound. J Med Assoc Thai 2008;91:1072–1075.

93. Mergo PJ, Ros PR. Benign lesions of the liver. Radiol Clin North Am 1998;36:319–331.

94. Gandolfi L, Leo P, Solmi L et al. Natural history of hepatic haemangiomas: clinical and ultrasound study. Gut 1991;32:677–680.

95. Saegusa T, Ito K, Oba N et al. Enlargement of multiple cavernous hemangioma of the liver in association with pregnancy. Intern Med 1995;34:207–211.

96. Conter RL, Longmire WP Jr. Recurrent hepatic hemangiomas. Possible association with estrogen therapy. Ann Surg 1988;207:115–119.

97. Gemer O, Moscovici O, Ben-Horin CL et al. Oral contraceptives and liver hemangioma: a case-control study. Acta Obstet Gynecol Scand 2004;83:1199–1201.

98. Tait N, Richardson AJ, Muguti G et al. Hepatic cavernous haemangioma: a 10 year review. Aust N Z J Surg 1992;62:521–524.

99. Park WC, Rhillips R. The role of radiation therapy in the management of hemangiomas of the liver. JAMA 1970;212:1496–1498.

100. Kasabach HH, Merritt KK. Capillary hemangioma with extensive purpura: report of a case. Am J Dis Children 1940;59:1063–1070.

101. Quaia E, Calliada F, Bertolotto M et al. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoridefilled microbubble contrast agent: diagnostic performance and confidence. Radiology 2004;232:420–430.

102. Farges O, Daradkeh S, Bismuth H. Cavernous hemangiomas of the liver: are there any indications for resection? World J Surg 1995;19:19–24.

103. Ehrl D, Rothaug K, Herzog P et al. ‘Incidentaloma’ of the liver: management of a diagnostic and therapeutic dilemma. HPB Surg 2012;2012:891787.

<…>

134. Trotter JF, Everson GT. Benign focal lesions of the liver. Clin Liver Dis 2001;5:17–42, v.

137. Sanfelippo PM, Beahrs OH, Weiland LH. Cystic disease of the liver. Ann Surg 1974;179:922–925.

138. Caremani M, Vincenti A, Benci A et al. Ecographic epidemiology of non-parasitic hepatic cysts. J Clin Ultrasound 1993;21:115–118.

139. Carrim ZI, Murchison JT. The prevalence of simple renal and hepatic cysts detected by spiral computed tomography. Clin Radiol 2003;58:626–629.

140. Gaines PA, Sampson MA. The prevalence and characterization of simple hepatic cysts by ultrasound examination. Br J Radiol 1989;62:335–337.

141. Larssen TB, Rorvik J, Hoff SR et al. The occurrence of asymptomatic and symptomatic simple hepatic cysts. A prospective, hospital-based study. Clin Radiol 2005;60:1026–1029.

142. Oto A, Tamm EP, Szklaruk J. Multidetector row CT of the liver. Radiol Clin North Am 2005;43:827–848, vii.

143. Ammori BJ, Jenkins BL, Lim PC et al. Surgical strategy for cystic diseases of the liver in a western hepatobiliary center. World J Surg 2002;26:462–469.

144. Bahirwani R, Reddy KR. Review article: the evaluation of solitary liver masses. Aliment Pharmacol Ther 2008;28:953–965.

145. Nisenbaum HL, Rowling SE. Ultrasound of focal hepatic lesions. Semin Roentgenol 1995;30:324–346.

146. Charlesworth P, Ade-Ajayi N, Davenport M. Natural history and long-term follow-up of antenatally detected liver cysts. J Pediatr Surg 2007;42:494–499.

147. Reid-Lombardo KM, Khan S, Sclabas G. Hepatic cysts and liver abscess. Surg Clin North Am 2010;90:679–697.

148. Gadzijev E, Dragan S, Verica FM et al. Hepatobiliary cystadenoma protruding into the common bile duct, mimicking complicated hydatid cyst of the liver. Report of a case. Hepatogastroenterology 1995;42:1008–1010.

149. Taylor BR, Langer B. Current surgical management of hepatic cyst disease. Adv Surg 1997;31:127–148.

150. Doty JE, Tompkins RK. Management of cystic disease of the liver. Surg Clin North Am 1989;69:285–295.

151. Gall TM, Oniscu GC, Madhavan K et al. Surgical management and long-term follow-up of non-parasitic hepatic cysts. HPB (Oxford) 2009;11:235–241.

152. Gamblin TC, Holloway SE, Heckman JT et al. Laparoscopic resection of benign hepatic cysts: a new standard. J Am Coll Surg 2008;207:731–736.

153. Mazza OM, Fernandez DL, Pekolj J et al. Management of nonparasitic hepatic cysts. J Am Coll Surg 2009;209:733–739.

154. Moorthy K, Mihssin N, Houghton PW. The management of simple hepatic cysts: sclerotherapy or laparoscopic fenestration. Ann R Coll Surg Engl 2001;83:409–414.

155. Regev A, Reddy KR, Berho M et al. Large cystic lesions of the liver in adults: a 15-year experience in a tertiary center. J Am Coll Surg 2001;193:36–45.

156. Wahba R, Kleinert R, Prenzel K et al. Laparoscopic deroofing of nonparasitic liver cysts with or without greater omentum flap. Surg Laparosc Endosc Percutan Tech 2011;21:54–58.

157. Tocchi A, Mazzoni G, Costa G et al. Symptomatic nonparasitic hepatic cysts: options for and results of surgical management. Arch Surg 2002;137:154–158.

158. Erdogan D, van Delden OM, Rauws EA et al. Results of percutaneous sclerotherapy and surgical treatment in patients with symptomatic simple liver cysts and polycystic liver disease. World J Gastroenterol 2007;13:3095–3100.

159. Larssen TB, Rorvik J, Horn A et al. Biochemical and cytologic analysis of cystic contents in benign non-parasitic symptomatic hepatic cysts before and after ethanol sclerotherapy. Acta Radiol 2004;45:504–509.

160. Saini S, Mueller PR, Ferrucci JT Jr et al. Percutaneous aspiration of hepatic cysts does not provide definitive therapy. AJR Am J Roentgenol 1983;141:559–560.

161. Garcea G, Pattenden CJ, Stephenson J et al. Nine-year single-center experience with nonparastic liver cysts: diagnosis and management. Dig Dis Sci 2007;52:185–191.

162. Garcea G, Rajesh A, Dennison AR. Surgical management of cystic lesions in the liver. ANZ J Surg 2013;83:516–522.

163. Palanivelu C, Jani K, Malladi V. Laparoscopic management of benign nonparasitic hepatic cysts: a prospective nonrandomized study. South Med J 2006;99:1063–1067.

164. Fong ZV, Wolf AM, Doria C et al. Hemorrhagic hepatic cyst: report of a case and review of the literature with emphasis on clinical approach and management. J Gastrointest Surg 2012;16:1782–1789.

165. Emre A, Serin KR, Ozden I et al. Intrahepatic biliary cystic neoplasms: surgical results of 9 patients and literature review. World J Gastroenterol 2011;17:361–365.

166. Devaney K, Goodman ZD, Ishak KG. Hepatobiliary cystadenoma and cystadenocarcinoma. A light microscopic and immunohistochemical study of 70 patients. Am J Surg Pathol 1994;18:1078–1091.

167. Lam MM, Swanson PE, Upton MP et al. Ovarian-type stroma in hepatobiliary cystadenomas and pancreatic mucinous cystic neoplasms: an immunohistochemical study. Am J Clin Pathol 2008;129:211–218.

168. Lee JH, Chen DR, Pang SC et al. Mucinous biliary cystadenoma with mesenchymal stroma: expressions of CA 19–9 and carcinoembryonic antigen in serum and cystic fluid. J Gastroenterol 1996;31:732–736.

169. Lee JH, Lee KG, Park HK et al. Biliary cystadenoma and cystadenocarcinoma of the liver: 10 cases of a single center experience. Hepatogastroenterology 2009;56:844–849.

170. Ishak KG, Willis GW, Cummins SD et al. Biliary cystadenoma and cystadenocarcinoma: report of 14 cases and review of the literature. Cancer 1977;39:322–338.

171. Marsh JL, Dahms B, Longmire WP Jr. Cystadenoma and cystadenocarcinoma of the biliary system. Arch Surg 1974;109:41–43.

172. Kim JY, Kim SH, Eun HW et al. Differentiation between biliary cystic neoplasms and simple cysts of the liver: accuracy of CT. AJR Am J Roentgenol 2010;195:1142–1148.

173. Wilson SR, Burns PN, Muradali D et al. Harmonic hepatic US with microbubble contrast agent: initial experience showing improved characterization of hemangioma, hepatocellular carcinoma, and metastasis. Radiology 2000;215:153–161.

174. Williams DM, Vitellas KM, Sheafor D. Biliary cystadenocarcinoma: seven year follow-up and the role of MRI and MRCP. Magn Reson Imaging 2001;19:1203–1208.

175. Dixon E, Sutherland FR, Mitchell P et al. Cystadenomas of the liver: a spectrum of disease. Can J Surg 2001;44:371–376.

176. Hai S, Hirohashi K, Uenishi T et al. Surgical management of cystic hepatic neoplasms. J Gastroenterol 2003;38:759–764.

177. Hansman MF, Ryan JA Jr, Holmes JH IV et al. Management and long-term follow-up of hepatic cysts. Am J Surg 2001;181:404–410.

178. Sanchez H, Gagner M, Rossi RL et al. Surgical management of nonparasitic cystic liver disease. Am J Surg 1991;161:113–118; discussion 118–9.

179. Vogt DP, Henderson JM, Chmielewski E. Cystadenoma and cystadenocarcinoma of the liver: a single center experience. J Am Coll Surg 2005;200:727–733.

180. Delis SG, Touloumis Z, Bakoyiannis A et al. Intrahepatic biliary cystadenoma: a need for radical resection. Eur J Gastroenterol Hepatol 2008;20:10–14.

181. Jain P, Jha AK, Rai RR. Cystic hepatic metastasis from gastrointestinal stromal tumor prior to imatinib mimicking a liver abscess. J Gastrointestin Liver Dis 2009;18:121–122.

182. Drenth JP, Chrispijn M, Nagorney DM et al. Medical and surgical treatment options for polycystic liver disease. Hepatology 2010;52:2223–2230.

183. Chandok N. Polycystic liver disease: a clinical review. Ann Hepatol 2012;11:819–826.

184. Torres VE, Harris PC. Autosomal dominant polycystic kidney disease: the last 3 years. Kidney Int 2009;76:149–168.

185. Qian Q. Isolated polycystic liver disease. Adv Chronic Kidney Dis 2010;17:181–189.

186. Kwok MK, Lewin KJ. Massive hepatomegaly in adult polycystic liver disease. Am J Surg Pathol 1988;12:321–324.

187. Sallee M, Rafat C, Zahar JR et al. Cyst infections in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 2009;4:1183–1189.

188. Chauveau D, Fakhouri F, Grunfeld JP. Liver involvement in autosomal-dominant polycystic kidney disease: therapeutic dilemma. J Am Soc Nephrol 2000;11:1767–1775.

189. Caroli A, Antiga L, Cafaro M et al. Reducing polycystic liver volume in ADPKD: effects of somatostatin analogue octreotide. Clin J Am Soc Nephrol 2010;5:783–789.

190. Chrispijn M, Nevens F, Gevers TJ et al. The long-term outcome of patients with polycystic liver disease treated with lanreotide. Aliment Pharmacol Ther 2012;35:266–274.

191. Hogan MC, Masyuk TV, Page LJ et al. Randomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and liver disease. J Am Soc Nephrol 2010;21:1052–1061.

192. Serra AL, Poster D, Kistler AD et al. Sirolimus and kidney growth in autosomal dominant polycystic kidney disease. N Engl J Med 2010;363:820–829.

193. Tao Y, Kim J, Schrier RW et al. Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease. J Am Soc Nephrol 2005;16:46–51.

194. van Keimpema L, Nevens F, Vanslembrouck R et al. Lanreotide reduces the volume of polycystic liver: a randomized, double-blind, placebocontrolled trial. Gastroenterology 2009;137:1661–1668 e1–2.

195. Walz G, Budde K, Mannaa M et al. Everolimus in patients with autosomal dominant polycystic kidney disease. N Engl J Med 2010;363:830–840.

196. Robinson TN, Stiegmann GV, Everson GT. Laparoscopic palliation of polycystic liver disease. Surg Endosc 2005;19:130–132.

197. Aussilhou B, Doufle G, Hubert C et al. Extended liver resection for polycystic liver disease can challenge liver transplantation. Ann Surg 2010;252:735–743.

198. Que F, Nagorney DM, Gross JB Jr et al. Liver resection and cyst fenestration in the treatment of severe polycystic liver disease. Gastroenterology 1995;108:487–494.

199. Kirchner GI, Rifai K, Cantz T et al. Outcome and quality of life in patients with polycystic liver disease after liver or combined liver-kidney transplantation. Liver Transpl 2006;12:1268–1277.

200. Morgan DE, Lockhart ME, Canon CL et al. Polycystic liver disease: multimodality imaging for complications and transplant evaluation. Radiographics 2006;26:1655–1668; quiz 1655.

201. Russell RT, Pinson CW. Surgical management of polycystic liver disease. World J Gastroenterol 2007;13:5052–5059.

202. Schnelldorfer T, Torres VE, Zakaria S et al. Polycystic liver disease: a critical appraisal of hepatic resection, cyst fenestration, and liver transplantation. Ann Surg 2009;250:112–118.

203. Chandok N, Uhanova J, Marotta P. Clinical outcomes of liver transplantation for polycystic liver disease: a single center experience. Ann Hepatol 2010;9:278–281.

204. van Keimpema L, Nevens F, Adam R et al. Excellent survival after liver transplantation for isolated polycystic liver disease: an European Liver Transplant Registry study. Transpl Int 2011;24:1239–1245.

205. WHO Informal Working Group. International classification of ultrasound images in cystic echinococcosis for application in clinical and field epidemiological settings. Acta Trop 2003;85:253–261.

206. von Sinner WN. New diagnostic signs in hydatid disease; radiography, ultrasound CT and MRI correlated to pathology. Eur J Radiol 1991;12:150–159.

207. WHO Informal Working Group on Echinococcosis. Guidelines for treatment of cystic and alveolar echinococcosis in humans. Bull World Health Organ 1996;74:231–242.

208. Stojkovic M, Zwahlen M, Teggi A et al. Treatment response of cystic echinococcosis to benzimidazoles: a systematic review. PLoS Negl Trop Dis 2009;3:e524.

209. Kjossev KT, Losanoff JE. Classification of hydatid liver cysts. J Gastroenterol Hepatol 2005;20:352–359.

210. Smego RA Jr, Bhatti S, Khaliq AA et al. Percutaneous aspiration-injection-reaspiration drainage plus albendazole or mebendazole for hepatic cystic echinococcosis: a meta-analysis. Clin Infect Dis 2003;37:1073–1083.

211. Brunetti E, Kern P, Vuitton DA et al. Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans. Acta Trop 2010;114:1–16.

212. Nasseri Moghaddam S, Abrishami A, Malekzadeh R. Percutaneous needle aspiration, injection, and reaspiration with or without benzimidazole coverage for uncomplicated hepatic hydatid cysts. Cochrane Database Syst Rev 2006:1: CD003623.

213. Sahin M, Kartal A, Haykir R et al. RF-assisted cystectomy and pericystectomy: a new technique in the treatment of liver hydatid disease. Eur Surg Res 2006;38:90–93.

214. Yagci G, Ustunsoz B, Kaymakcioglu N et al. Results of surgical, laparoscopic, and percutaneous treatment for hydatid disease of the liver: 10 years experience with 355 patients. World J Surg 2005;29:1670–1679.

215. Zacharoulis D, Poultsidis A, Roundas C et al. Liver hydatid disease: radiofrequency-assisted pericystectomy. Ann R Coll Surg Engl 2006;88:499–500.

216. Khuroo MS, Dar MY, Yattoo GN et al. Percutaneous drainage versus albendazole therapy in hepatic hydatidosis: a prospective, randomized study. Gastroenterology 1993;104:1452–1459.

217. Khuroo MS, Wani NA, Javid G et al. Percutaneous drainage compared with surgery for hepatic hydatid cysts. N Engl J Med 1997;337:881–887.

218. Giorgio A, Tarantino L, de Stefano G et al. Hydatid liver cyst: an 11-year experience of treatment with percutaneous aspiration and ethanol injection. J Ultrasound Med 2001;20:729–738.

219. Kabaalioglu A, Ceken K, Alimoglu E et al. Percutaneous imaging-guided treatment of hydatid liver cysts: do long-term results make it a first choice? Eur J Radiol 2006;59:65–73.

220. Neumayr A, Troia G, de Bernardis C et al. Justified concern or exaggerated fear: the risk of anaphylaxis in percutaneous treatment of cystic echinococcosis-a systematic literature review. PLoS Negl Trop Dis 2011;5:e1154.

221. Daradkeh S, El-Muhtaseb H, Farah G et al. Predictors of morbidity and mortality in the surgical management of hydatid cyst of the liver. Langenbecks Arch Surg 2007;392:35–39.

222. Koea JB. Laparoscopic treatment of hepatic hydatid disease. ANZ J Surg 2012;82:499–504.

223. Palanivelu C, Jani K, Malladi V et al. Laparoscopic management of hepatic hydatid disease. JSLS 2006;10:56–62.

224. Dziri C, Haouet K, Fingerhut A et al. Management of cystic echinococcosis complications and dissemination: where is the evidence? World J Surg 2009;33:1266–1273.

225. Smego RA Jr, Sebanego P. Treatment options for hepatic cystic echinococcosis. Int J Infect Dis 2005;9:69–76.